Joined Today: 2

ISPH Inspire Pharmaceuticals, Stock Message Board

All Messages

ISPH Message Board Home | Join The ISPH Group |

#46: Inspire Announces Webcast of Presentation at UBS Conference
TheMachine	September 20, 2008 02:21:23 AM
Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that Thomas R. Staab, II, CFO and Treasurer, will present at the UBS Global Life Sciences Conference on... view message ignore post recommend post

#45: Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
TheMachine	September 20, 2008 02:20:59 AM
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that the standard 30-day review period by the U.S. Food and Drug Administration (FDA) relating to Inspire’s... view message ignore post recommend post

#44: Re: Inspire Initiates Phase 3 Trial of Epinastine Nasal Spray for Allergic Rhinitis
FastFun	November 30, 2007 11:44:40 AM
Phase 3! How long is phase 3 last? view message view parent message ignore post recommend post

#43: Inspire Initiates Phase 3 Trial of Epinastine Nasal Spray for Allergic Rhinitis
FastFun	November 30, 2007 11:42:36 AM
Top-line Results Expected Second Quarter 2008 Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the initiation of a Phase 3 clinical trial to evaluate epinastine nasal spray... view message ignore post recommend post

#42: Inspire Announces Oral Presentation of Phase 2 Epinastine Nasal Spray Data at American College of Allergy, Asthma & Immunology Meeting
FastFun	November 27, 2007 09:11:59 PM
Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that a presentation of its Phase 2 clinical trial data on epinastine nasal spray for the treatment of allergic rhinitis will be given... view message ignore post recommend post

#41: ISPH News Inspire Announces Webcast of Presentation at Cowen and Company's 27th Annual Health Care Conference
NewsBot	March 6, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, will present at Cowen and Company’s... view message ignore post recommend post

#40: ISPH News Inspire Reports Fourth Quarter and Full Year 2006 Financial Results
NewsBot	February 27, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today financial results for the fourth quarter and year ended December 31, 2006, reporting a net... view message ignore post recommend post

#39: ISPH News Inspire to Present Data at 2007 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
NewsBot	February 23, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Inspire scientists and collaborators will present information at the 2007 American... view message ignore post recommend post

#38: ISPH News Inspire Announces Webcast of Presentation at Susquehanna Healthcare Conference
NewsBot	February 22, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Thomas R. Staab, II, Chief Financial Officer and Treasurer, and Donald J. Kellerman,... view message ignore post recommend post

#36: ISPH News Inspire Announces Executive Management Promotions
NewsBot	February 20, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the following executive management promotions. Benjamin R. Yerxa, Ph.D. has been... view message ignore post recommend post

#37: ISPH News Inspire Announces Executive Management Promotions
NewsBot	February 20, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the following executive management promotions. Benjamin R. Yerxa, Ph.D. has been... view message ignore post recommend post

#35: ISPH News Inspire Licenses AzaSite(TM) For Ocular Infections
NewsBot	February 16, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the signing of an exclusive licensing agreement with InSite Vision Incorporated (AMEX: ISV)... view message ignore post recommend post

#34: ISPH News Inspire Director Alan F. Holmer Resigns Board Position to Accept Senior Post in Bush Administration
NewsBot	February 13, 2007 01:30:00 PM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Alan F. Holmer has resigned from the Board of Directors of Inspire Pharmaceuticals,... view message ignore post recommend post

#33: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2006 Financial Results
NewsBot	February 13, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that it plans to report fourth quarter and full year 2006 financial results on Tuesday,... view message ignore post recommend post

#32: ISPH News Inspire Provides Cystic Fibrosis Clinical Program Update
NewsBot	January 16, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today announced an update on its clinical development program for denufosol tetrasodium for the treatment... view message ignore post recommend post

Group Home | Login if you want to post a message